';
Authors Posts by Melissa Dehoff

Melissa Dehoff

848 POSTS 0 COMMENTS
Melissa Dehoff is responsible for all medical rehabilitation and brain injury service issues. Ms. Dehoff attends multiple state-level meetings to advocate on behalf of members on brain injury and rehabilitation issues and is a member of the Department of Health Traumatic Brain Injury Advisory Board.

Image by PIRO4D from Pixabay

On July 19, 2021, the Department of Health and Human Services (HHS) Secretary Xavier Becerra announced the renewal of the national Public Health Emergency (PHE) due to the COVID-19 pandemic. The declaration of the PHE will remain in effect for 90 days unless renewed again, which HHS has done (five times). The PHE status enables the Centers for Medicare and Medicaid Services (CMS) to keep in place many waivers of Medicare rules.

The Traumatic Brain Injury (TBI) Advisory Board, established under section 1252 of the Federal Traumatic Brain Injury Act of 1996 (42 U.S.C.A. § 300d-52), will hold their next virtual public meeting on August 6, 2021. Due to health concerns related to the novel coronavirus (COVID-19), the virtual public meeting will be held by means of Microsoft Teams from 9:00 am–1:00 pm.

Meeting materials will be sent out before the virtual public meeting. Contact Nicole Johnson with any questions. To join the Microsoft Teams virtual public meeting, call (267) 332-8737. The conference ID is 800547238#.

The Department of Health’s (DOH) Head Injury Program (HIP) strives to ensure that eligible individuals who have a TBI receive high quality rehabilitative services aimed at reducing functional limitations and improving quality of life. The Board assists the Department in understanding and meeting the needs of persons living with TBI and their families. This quarterly virtual public meeting will provide updates on a variety of topics, including the number of people served by HIP. In addition, meeting participants will discuss budgetary and programmatic issues, community programs relating to traumatic brain injury, and available advocacy opportunities.

For additional information, or for persons with a disability who wish to attend the virtual public meeting and require an auxiliary aid, service, or other accommodation to do so, contact Nicole Johnson, Division of Community Systems Development and Outreach at (717) 772-2763, or for speech and/or hearing-impaired persons, contact V/TT (717) 783-6514 or the Pennsylvania Hamilton Relay Service at (800) 654-5984.

0 1359

The Centers for Medicare and Medicaid Services (CMS) recently announced that the next Hospital/Quality Initiative Open Door Forum will take place on July 20, 2021, from 3:00 pm–4:00 pm. Agenda topics include:

Announcements & Updates

Open Q&A
*COVID-19 related questions are welcome*

To participate, dial: 888-455-1397 and reference passcode: 8604468. The call will be recorded and can be accessed by dialing: 866-347-5805 (no passcode is needed). The recording will expire after July 22, 2021.

The next Managed Long-Term Services and Supports (MLTSS) Subcommittee meeting has been scheduled for August 5, 2021 (via webinar) from 10:00 am–1:00 pm.

As a reminder, public comments will be taken after each presentation. Questions can be entered into the chat box during the presentations, and these questions will be asked at the end of each presentation. There will be an additional period at the end of the meeting for any additional public comments.

The Department of Human Services (DHS) Office of Long-Term Living (OLTL) is using technology that allows individuals to participate in the webinar and listen through computer speakers instead of participating by dial-in. Dial-in will still be available if you do not choose to participate by webinar, but the number is no longer toll free.

To participate in the meeting via webinar, please register here. Registrants will receive a confirmation email containing information about joining the webinar. To participate via telephone, the dial-in information is: (562)-247-8321; Access Code: 541-873-565.

The Centers for Medicare and Medicaid Services (CMS) has released the calendar year (CY) 2022 Medicare Physician Fee Schedule (MPFS) proposed payment rule. Some of the proposed provisions include:

CY 2022 Physician Fee Schedule (PFS) Payment Rate Update

With the proposed budget neutrality adjustment to account for changes in RVUs (required by law), and expiration of the 3.75 percent payment increase provided for CY 2021 by the Consolidated Appropriations Act, 2021 (CAA), the proposed CY 2022 PFS conversion factor is $33.58, a decrease of $1.31 from the CY 2021 PFS conversion factor of $34.89. The PFS conversion factor reflects the statutory update of 0.00 percent and the adjustment necessary to account for changes in relative value units and expenditures that would result from our proposed policies.

Evaluation and Management (E/M) Visits

CMS is engaged in an ongoing review of payment for E/M visit code sets. For CY 2022, there are several proposals that take into account the recent changes to E/M visit codes, as explained in the AMA CPT Codebook, which took effect January 1, 2021. CMS is also proposing to clarify and refine policies that were reflected in certain manual provisions that were recently withdrawn.

CMS is proposing to refine their longstanding policies for split (or shared) E/M visits to better reflect the current practice of medicine, the evolving role of non-physician practitioners (NPPs) as members of the medical team, and to clarify conditions of payment that must be met to bill Medicare for these services. In the CY 2022 PFS proposed rule, the following is proposed:

  • Definition of split (or shared) E/M visits as evaluation and management (E/M) visits provided in the facility setting by a physician and an NPP in the same group.
  • The practitioner who provides the substantive portion of the visit (more than half of the total time spent) would bill for the visit.
  • Split (or shared) visits could be reported for new as well as established patients, and initial and subsequent visits, as well as prolonged services.
  • Requiring reporting of a modifier on the claim to help ensure program integrity.
  • Documentation in the medical record that would identify the two individuals who performed the visit. The individual providing the substantive portion must sign and date the medical record.

Telehealth Services under the PFS

CMS continues to evaluate the temporary expansion of telehealth services that were added to the telehealth list during the COVID-19 public health emergency (PHE) and is proposing to allow certain services added to the Medicare telehealth list to remain on the list to the end of December 31, 2023, so that there is a path to evaluate whether the services should be permanently added to the telehealth list following the COVID-19 PHE. Section 123 of the CAA removed the geographic restrictions and added the home of the beneficiary as a permissible originating site for telehealth services when used for the purposes of diagnosis, evaluation, or treatment of a mental health disorder, and requires that there be an in-person, non-telehealth service with the physician or practitioner within six months prior to the initial telehealth service, and thereafter, at intervals as specified by the Secretary.

CMS is proposing to require an in-person, non-telehealth service be provided by the physician or practitioner furnishing mental health telehealth services within six months prior to the initial telehealth  service, and at least once every six months thereafter. CMS is requesting feedback on whether a different interval may be necessary or appropriate for mental health services furnished through audio-only communication technology. CMS is also seeking comment on how to address scenarios where a physician or practitioner of the same specialty/subspecialty in the same group may need to furnish a mental health service due to unavailability of the beneficiary’s regular practitioner.

CMS is also soliciting comment on: (1) whether additional documentation should be required in the patient’s medical record to support the clinical appropriateness of audio-only telehealth; (2) whether or not we should preclude audio-only telehealth for some high-level services, such as level 4 or 5 E/M visit codes or psychotherapy with crisis; and (3) any additional guardrails we should consider putting in place in order to minimize program integrity and patient safety concerns.

Therapy Services

CMS is implementing the final part of section 53107 of the Bipartisan Budget Act of 2018, which requires CMS, through the use of new modifiers (CQ and CO), to identify and make payment at 85 percent of the otherwise applicable Part B payment amount for physical therapy and occupational therapy services furnished in whole or in part by physical therapist assistants (PTAs) and occupational therapy assistants (OTAs), for dates of service on and after January 1, 2022.

For CY 2022, in response to numerous stakeholder questions and to promote proper therapy care, CMS is proposing to revise the de minimis standard established to determine whether services are provided “in whole or in part” by PTAs or OTAs. Specifically, CMS is proposing to revise the de minimis policy to allow a timed service to be billed without the CQ/CO modifier in cases when a PTA/OTA participates in providing care to a patient with a physical therapist or occupational therapist (PT/OT), but the PT/OT meets the Medicare billing requirements for the timed service without the minutes furnished by the PTA/OTA by providing more than the 15-minute midpoint (also known as the 8-minute rule).

Overall, the de minimis standard would continue to be applicable in the following scenarios:

  • When the PTA/OTA independently furnishes a service, or a 15-minute unit of a service “in whole” without the PT/OT furnishing any part of the same service.
  • In instances where the service is not defined in 15-minute increments including:  supervised modalities, evaluations/reevaluations, and group therapy.
  • When the PTA/OTA furnishes eight minutes or more of the final unit of a billing scenario in which the PT/OT furnishes less than eight minutes of the same service.
  • When both the PTA/OTA and the PT/OT each furnish less than eight minutes for the final 15-minute unit of a billing scenario.

Physician Assistant (PA) Services

CMS is proposing to implement section 403 of Division CC of the CAA that authorizes Medicare to make direct payment to PAs for professional services they furnish under Part B beginning January 1, 2022. Medicare currently can only make payment to the employer or independent contractor of a PA. Consequently, PAs could not bill and be paid by the Medicare program directly for their professional services; they also did not have the option to reassign payment for their services or to incorporate with other PAs to bill the program for PA services. Beginning January 1, 2022, PAs would be able to bill Medicare directly for their services and reassign payment for their services.

Vaccine Administration Services Comment Solicitation

Over the last several years, Medicare payment rates for physicians and mass immunizers for administering certain preventive vaccines (flu, pneumonia and hepatitis B vaccines) have decreased by approximately 30 percent. Given the ongoing stakeholder interest in this issue, the proposed rule includes a comment solicitation to obtain information on the costs involved in furnishing preventive vaccines, with the goal to inform the development of more accurate rates for these services. More specifically CMS is seeking information on:

  • The different types of health care providers who furnish vaccines and how have those providers changed since the start of the pandemic.
  • How the costs of furnishing flu, pneumococcal, and hepatitis B vaccines compare to the costs of furnishing COVID-19 vaccines, and how costs may vary for different types of health care providers.
  • How the COVID-19 PHE may have impacted costs, and whether health care providers envision these costs to continue.

CMS is also seeking stakeholder input on a proposed policy to pay $35 add-on for certain vulnerable beneficiaries when they receive a COVID-19 vaccine at home. CMS is interested in stakeholder input on what qualifies as the “home” and how they can balance ensuring program integrity with beneficiary access. CMS is also seeking comments on whether they should treat these products the same way we treat other physician-administered drugs and biologicals under Medicare Part B.

Opioid Treatment Program (OTP) Payment Policy

CMS is proposing to allow OTPs to furnish counseling and therapy services via audio-only interaction (such as telephone calls) after the conclusion of the COVID-19 PHE in cases where audio/video communication is not available to the beneficiary, including circumstances in which the beneficiary is not capable of or does not consent to the use of devices that permit a two-way audio/video interaction, provided all other applicable requirements are met. CMS is proposing to require that OTPs use a service-level modifier for audio-only services billed using the counseling and therapy add-on code and document in the medical record the rationale for a service being furnished using audio-only services, in order to facilitate program integrity activities.

The proposed rule will be published in the July 23, 2021 Federal Register. Comments will be accepted until September 13, 2021.

Today, the Centers for Medicare and Medicaid Services (CMS) announced they will be opening a National Coverage Determination (NCD) analysis on the treatment for Alzheimer’s disease. This NCD process will allow CMS to carefully review and determine whether Medicare will establish a national Medicare coverage policy for monoclonal antibodies targeting amyloid for the treatment of Alzheimer’s disease. NCDs are program instructions developed by CMS to describe the nationwide conditions for Medicare coverage for a specific item or service. This NCD analysis will be applicable to national coverage considerations for aducanumab, which was recently approved by the Food and Drug Administration (FDA), as well as any future monoclonal antibodies that target amyloid for the treatment of Alzheimer’s disease.

Currently, coverage determinations for aducanumab are being made at the local level by Medicare Administrative Contractors (MACs) who represent 12 jurisdictions across the country. CMS’s coverage decisions are based on careful analysis of the evidence and benefits a given therapy provides to Medicare beneficiaries. To determine whether a national policy is appropriate, CMS will follow a standard process that includes multiple opportunities for the public to participate and present comments through both listening sessions and the CMS Coverage website. The analysis will determine whether the evidence meets the Medicare law’s requirements that items or services be “reasonable and necessary for the diagnosis or treatment of illness or injury….” To make this determination, CMS uses a formal process established by statute. The process includes an assessment of the clinical evidence such as published clinical studies, professional society guidelines, and public comments to determine coverage.

Following this analysis, CMS will post a proposed NCD, which will be open to a second 30-day public comment period. After reviewing all comments received on a proposed determination, CMS will announce its final decision for a national policy which could range from Medicare coverage of this product type, coverage with evidence development, non-coverage, or deference to the Medicare Administrative Contractors. A proposed decision is expected to be posted within 6 months and a final within 9 months.

As part of the NCD process, a 30-day public comment period will begin today. CMS will also host two public listening sessions in July to provide an opportunity for public input.

To register for the listening sessions:
July 22, 2021 from 9:00 am–11:00 am (EDT) or
July 27, 2021 from 2:00 pm–4:00 pm (EDT)

NCDs are posted on the CMS Medicare Coverage Center website and provide stakeholders with the Medicare coverage criteria, a summary of the evidence considered, and CMS’s rationale for the decision. Comments can be submitted and viewed here.

The documents from the July 7, 2021 Managed Long-Term Services and Supports (MLTSS) Subcommittee meeting are now available. Included in these documents are:

  • Agenda
  • OLTL Updates
  • Medicaid Research Center’s (University of Pittsburgh) Presentation: Community HealthChoices (CHC) Participant Experience: Before and After Implementation
  • Community HealthChoices Managed Care Organizations (CHC MCO) Contact Center Presentations
  • MLTSS Subcommittee Transcript

The next MLTSS Subcommittee meeting is scheduled for August 5, 2021.

The Centers for Medicare and Medicaid Services (CMS) recently released an updated COVID-19 Accelerated and Advance Payment (CAAP) Repayment & Recovery Frequently Asked Questions (FAQ) document. Members are encouraged to review this document to learn more about how recoupment works and how it affects Medicare claims payment amounts.

Photo by Leon on Unsplash

During yesterday’s Managed Long-Term Services and Supports Subcommittee (MLTSS) meeting, a presentation was provided by Dr. Howard Degenholz from the Medicaid Research Center at the Health Policy Institute of University of Pittsburgh, which focused on the outcome/feedback of a Community HealthChoices (CHC) Evaluation and the participant experience. This group evaluated the participant experience and their satisfaction with CHC. A variety of participants utilizing CHC were selected; however, specific diagnoses were not included in the selection process.

This group is now planning follow-up CHC 2021 Innovation focus group meetings with providers that will focus on three specific areas: Housing Issues, Employment Issues, and Transportation Issues. Providers/members are encouraged to sign up for these meetings that are scheduled for the end of July/beginning of August.

0 700

The Centers for Medicare and Medicaid Services (CMS) recently released the Calendar Year (CY) 2022 Home Health Prospective Payment System (HH PPS) Proposed Rule, which includes a provision that would impact the inpatient rehabilitation facility (IRF) quality reporting program (QRP).

If finalized, this provision would require IRFs to begin utilizing the IRF Patient Assessment Instrument (PAI) v4.0 on October 1, 2022. The IRF PAI v4.0 was originally scheduled to begin on October 2, 2020; however, due to the COVID-19 public health emergency (PHE), CMS delayed implementation until October 1 of one full fiscal year after conclusion of the PHE through an interim final rule. The IRF PAI v4.0 includes the Transfer of Health (TOH) Information – Patient and TOH Information – Provider ‎measures, as well as certain Standardized Patient Assessment Data Elements (SPADEs). CMS noted that they believe IRFs are able to begin the administrative processes needed to implement the ‎IRF PAI v4.0, and that v4.0 will allow CMS to better support a January 2021 Executive Order aimed at ‎addressing equity.‎

The CY 2022 HH PPS proposed rule will be published in the July 7, 2021 Federal Register.